The burgeoning hope surrounding classic psychedelics as a transformative treatment for depression is beginning to confront the sobering realities of…
Read More

The burgeoning hope surrounding classic psychedelics as a transformative treatment for depression is beginning to confront the sobering realities of…
Read More
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in a quest for a safer anesthetic, the…
Read More
The fervent hope surrounding classic psychedelics as a revolutionary treatment for depression may be tempering, with recent data suggesting that…
Read More
Johnson & Johnson is intensifying its efforts to expand the market footprint of Spravato (esketamine) for treatment-resistant depression (TRD), leveraging…
Read More
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis while searching for a safer anesthetic, the molecule…
Read More
Autobahn Therapeutics has announced a significant milestone in its development of elunetirom, a novel central nervous system (CNS)-directed thyroid hormone…
Read More
A landmark study published in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences has unveiled a significant…
Read More
The landscape of psychiatric medicine is undergoing a fundamental shift as researchers move away from purely symptomatic assessments toward objective…
Read More
The landscape of psychiatric medicine is undergoing a significant shift as researchers move closer to replacing subjective symptom reporting with…
Read More
A groundbreaking study led by researchers at McGill University and the Douglas Research Centre has fundamentally altered the scientific understanding…
Read More